The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Activity of sorafenib in radiation-associated breast angiosarcomas harboring MYC and FLT4 amplifications.
Sandra P. D'Angelo
No relevant relationships to disclose
Cristina R. Antonescu
No relevant relationships to disclose
Mary Louise Keohan
No relevant relationships to disclose
Richard D. Carvajal
No relevant relationships to disclose
Mark Andrew Dickson
No relevant relationships to disclose
Mrinal M. Gounder
No relevant relationships to disclose
Nicole H. Moraco
No relevant relationships to disclose
Samuel Singer
No relevant relationships to disclose
Gary K. Schwartz
No relevant relationships to disclose
William D. Tap
No relevant relationships to disclose